6 Change from average baseline eGFR of 45 mL/min/1.73 m 2 : -0.35 mL/min/1.73 m 2 2 with Victoza 1.8 mg ( P =0.36) 2 +0.37 mL/min/1.73 m 2 2 with placebo 2 No dosage adjustment recommended for patients with renal impairment 1 There is limited experience with Victoza in patients with end-stage renal disease
You can find it at hubermanlab.com & on all podcast platforms
Huber, Monika Kreyenbuehl, Heike Gutmann, Jrgen Drewe, Christoph Henzen, Burkhard Goeke, Christoph Beglinger, Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese Men, The Journal of Clinical Endocrinology & Metabolism , Volume 89, Issue 6, 1 June 2004, Pages 30553061, Weiss, E
Once Tesamorelin is administered, it stimulates the pituitary gland to release growth hormone
(2012) 302:E33443
Thyroid 20 , 13331339 (2010)